
CAS 1046447-90-8
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
JNJ-39758979
CAS :JNJ-39758979: selective H4 receptor antagonist, Kis 12.5/5.3/25 nM (human/mouse/monkey), blocks histamine cAMP inhibition (pA2 7.9).Formule :C11H19N5Degré de pureté :98.33% - 99.62%Couleur et forme :SolidMasse moléculaire :221.3Ref: TM-T11723L
1mg46,00€5mg92,00€10mg147,00€25mg241,00€50mg350,00€100mg515,00€200mg700,00€1mL*10mM (DMSO)100,00€JNJ 39758979 TFA Salt
CAS :Produit contrôléApplications JNJ 39758979, is a selective, high-affinity histamine H4 receptor antagonist with a Ki of 12.5 nM.
References Savall, B. M. et al.: J Med Chem. 2014 Mar 27;57(6):2429-39;Formule :C11H19N5·xC2HF3O2Couleur et forme :NeatMasse moléculaire :335.33JNJ 39758979
CAS :JNJ 39758979 is a small molecule compound, which is a selective antagonist of the P2X7 receptor. This receptor is a purinergic ligand-gated ion channel sourced from human and mammalian cell lines, prominent in neurobiological and immunological tissues. The mode of action involves the inhibition of the P2X7 receptor, which plays a crucial role in inflammatory processes and cell death signaling pathways. By blocking this receptor, JNJ 39758979 reduces the release of pro-inflammatory cytokines, thus modulating neuroinflammation.Formule :C11H19N5Degré de pureté :Min. 95%Masse moléculaire :221.3 g/mol



